Morgan Stanley Alert: Gilead Investors Don't Have The Whole Story By: Benzinga via Benzinga April 24, 2015 at 08:33 AM EDT In a report published Friday, Morgan Stanley analysts maintained an Overweight rating on Gilead Sciences, Inc. (NASDAQ: GILD). Headline ... Read More >> Related Stocks: Gilead Sciences Merck & Co